Employees: 02 (2023.0)Legal category: 5785Size: PMECreation date: 2014-12-29 (11 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: STAFFELFELDEN (68850), Haut-Rhin
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
S.E.L.A.S. PHARMACIE DES MINES : revenue, balance sheet and financial ratios
S.E.L.A.S. PHARMACIE DES MINES is a French company
founded 11 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in STAFFELFELDEN (68850),
this company of category PME
shows in 2024 a net income positive of 25 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - S.E.L.A.S. PHARMACIE DES MINES (SIREN 809262835)
Indicator
2024
2023
2022
2021
2020
2019
2018
2016
2015
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
25 431 €
58 €
405 €
31 192 €
67 910 €
8 463 €
32 385 €
62 912 €
15 628 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
-627 034 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, S.E.L.A.S. PHARMACIE DES MINES generates positive net income of 25 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2024: 16 k€ -> 25 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
25 431 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 156%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 11%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
156.15%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
11.466%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution S.E.L.A.S. PHARMACIE DES MINES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2018
2019
2020
2021
2022
2023
2024
Debt ratio
330.034
36.118
50.087
37.253
3.34
0.234
657.606
1300.899
156.15
Financial autonomy
11.85
26.186
44.461
29.012
37.22
40.971
2.037
3.372
11.466
Repayment capacity
4.986
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
156.152024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average
In 2024, the debt ratio of S.E.L.A.S. PHARMACIE DES ... (156.15) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
11.47%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch
In 2024, the financial autonomy of S.E.L.A.S. PHARMACIE DES ... (11.5%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 124.72. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
124.724
Liquidity indicators evolution S.E.L.A.S. PHARMACIE DES MINES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
137.658
101.655
221.098
139.418
151.208
159.113
110.948
170.713
124.724
Interest coverage
-0.4
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
124.722024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Watch
In 2024, the liquidity ratio of S.E.L.A.S. PHARMACIE DES ... (124.72) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution S.E.L.A.S. PHARMACIE DES MINES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2018
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
0
0
0
Customer payment term (days)
0
0
241
0
0
0
0
0
0
Supplier payment term (days)
49
0
586
0
0
0
0
0
0
Positioning of S.E.L.A.S. PHARMACIE DES MINES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of S.E.L.A.S. PHARMACIE DES MINES is estimated at
355 035 €
(range 247 241€ - 531 153€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
247k€355k€531k€
355 035 €Range: 247 241€ - 531 153€
NAF 5 année 2024
Valuation method used
Net Income Multiple
25 431 €
×
14.0x
=355 036 €
Range: 247 241€ - 531 154€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare S.E.L.A.S. PHARMACIE DES MINES with other companies in the same sector:
Frequently asked questions about S.E.L.A.S. PHARMACIE DES MINES
What is the revenue of S.E.L.A.S. PHARMACIE DES MINES ?
The revenue of S.E.L.A.S. PHARMACIE DES MINES is not publicly disclosed (confidential accounts filed with INPI).
Is S.E.L.A.S. PHARMACIE DES MINES profitable?
Yes, S.E.L.A.S. PHARMACIE DES MINES generated a net profit of 25 k€ in 2024.
Where is the headquarters of S.E.L.A.S. PHARMACIE DES MINES ?
The headquarters of S.E.L.A.S. PHARMACIE DES MINES is located in STAFFELFELDEN (68850), in the department Haut-Rhin.
Where to find the tax return of S.E.L.A.S. PHARMACIE DES MINES ?
The tax return of S.E.L.A.S. PHARMACIE DES MINES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does S.E.L.A.S. PHARMACIE DES MINES operate?
S.E.L.A.S. PHARMACIE DES MINES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart